A study to examine the influence of repaglinide on the 'incretin effect' and oxidative damage associated with postprandial.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2011
At a glance
- Drugs Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 28 Aug 2011 New trial record